{
  "url": "https://www.nasdaq.com/article/health-care-sector-update-for-09042019-opgn-pbyi-codx-jnj-pfe-abt-mrk-amgn-cm1207153",
  "title": "Health Care Sector Update for 09/04/2019: OPGN, PBYI, CODX, JNJ, PFE, ABT, MRK, AMGN - Nasdaq.com",
  "text": [
    "Top Health Care Stocks:",
    "JNJ: +0.40%",
    "PFE: +0.78%",
    "ABT: Flat",
    "MRK: +0.98%",
    "AMGN: +0.50%",
    "Top health care stocks were climbing pre-bell Wednesday.",
    "Early movers include:",
    "(+) OpGen ( OPGN  ), which was surging more than 64% after the company and Curetis agreed to merge into a commercial-stage molecular diagnostics and bioinformatics company with a focus on infectious diseases and antimicrobial resistance.",
    "(+) Puma Biotechnology ( PBYI  ) was up almost 9% as the US Food and Drug Administration granted orphan drug designation for the company's Nerlynx drug to treat breast cancer patients with brain metastases.",
    "(+) Co-Diagnostics ( CODX  ) was gaining more than 8% in value after the company and LGC, Biosearch Technologies said pre-market Wednesday that they are expanding their license agreement related to the use of a coprimer polymerase chain reaction technology platform.",
    "\nThe views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.\n",
    "\nCopyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.\n"
  ],
  "published_datetime": "2019-09-04 09:17:02"
}